國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Multiple myeloma and other plasma ce...

Dimopoulos, Meletios A.

Multiple myeloma and other plasma cell neoplasms

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Multiple myeloma and other plasma cell neoplasmsedited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos.
其他作者:	Dimopoulos, Meletios A.
出版者:	Cham :Springer International Publishing :2018.
面頁冊數:	vi, 245 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Multiple myeloma.
電子資源:	http://dx.doi.org/10.1007/978-3-319-25586-6
ISBN:	9783319255866$q(electronic bk.)

Multiple myeloma and other plasma cell neoplasms
Multiple myeloma and other plasma cell neoplasms[electronic resource] /edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos. - Cham :Springer International Publishing :2018. - vi, 245 p. :ill., digital ;24 cm. - Hematologic malignancies,2197-9766. - Hematologic malignancies..

This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenstrom's macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management.

ISBN: 9783319255866$q(electronic bk.)

Standard No.: 10.1007/978-3-319-25586-6doiSubjects--Topical Terms:

470645
Multiple myeloma.

LC Class. No.: RC280.B6

Dewey Class. No.: 616.99418

Multiple myeloma and other plasma cell neoplasms
LDR:02113nmm a2200313 a 4500 001 531984
003 DE-He213
005 20180216105137.0
006 m d
007 cr nn 008maaau
008 181113s2018 gw s 0 eng d
020 $a 9783319255866$q(electronic bk.)
020 $a 9783319255842$q(paper)
024 7 $a 10.1007/978-3-319-25586-6 $2 doi
035 $a 978-3-319-25586-6
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B6
072 7 $a MJF $2 bicssc
072 7 $a MED038000 $2 bisacsh
082 0 4 $a 616.99418 $2 23
090 $a RC280.B6 $b M961 2018
245 0 0 $a Multiple myeloma and other plasma cell neoplasms $h [electronic resource] / $c edited by Meletios A. Dimopoulos, Thierry Facon, Evangelos Terpos.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2018.
300 $a vi, 245 p. : $b ill., digital ; $c 24 cm.
490 1 $a Hematologic malignancies, $x 2197-9766
520 $a This book is a comprehensive source of up-to-date information on plasma cell neoplasms. Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration. Examples include lenalidomide as first-line therapy, panobinostat in combination with bortezomib plus dexamethasone for relapsed/refractory myeloma, ibrutinib for Waldenstrom's macroglobulinemia, and new therapeutic regimens for systemic amyloidosis and POEMS syndrome. Information is also provided on drug combinations that have shown encouraging results and are very near to approval. Other important aspects covered in the book are the role of different imaging modalities in workup and the significance of newly acquired data relating to prognosis and minimal residual disease. Readers will find Multiple Myeloma and Other Plasma Cell Neoplasms to be a rich source of knowledge that will be invaluable in improving patient management.
650 0 $a Multiple myeloma. $3 470645
650 1 4 $a Medicine & Public Health. $3 273799
650 2 4 $a Hematology. $3 274899
650 2 4 $a Oncology. $3 195181
650 2 4 $a Immunology. $3 189152
700 1 $a Dimopoulos, Meletios A. $3 806762
700 1 $a Facon, Thierry. $3 806763
700 1 $a Terpos, Evangelos. $3 806764
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
830 0 $a Hematologic malignancies. $3 560151
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-25586-6
950 $a Medicine (Springer-11650)